81 FR 57922 - Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 81, Issue 164 (August 24, 2016)

Page Range57922-57922
FR Document2016-20198

In accordance with section 10(a)(2) of the Federal Advisory Committee Act, notice is hereby given of the following meeting of the Advisory Council on Blood Stem Cell Transplantation (ACBSCT).

Federal Register, Volume 81 Issue 164 (Wednesday, August 24, 2016)
[Federal Register Volume 81, Number 164 (Wednesday, August 24, 2016)]
[Notices]
[Page 57922]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, notice is hereby given of the following meeting of the 
Advisory Council on Blood Stem Cell Transplantation (ACBSCT).

DATES: 
September 13, 2016, from 8:00 a.m. to 4:00 p.m. Eastern Time.
September 14, 2016, from 8:00 a.m. to 12:30 p.m. Eastern Time.

ADDRESSES: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, 
Arlington, VA 22202.

FOR FURTHER INFORMATION CONTACT: Robert Walsh, Executive Secretary, 
Division of Transplantation, Healthcare Systems Bureau, Health 
Resources and Services Administration, 5600 Fishers Lane, Room 8W60, 
Rockville, MD 20857; telephone (301) 443-6839.

SUPPLEMENTARY INFORMATION: 
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (session 
379 of the Public Health Service Act, as amended), the ACBSCT advises 
the Secretary of the Department of Health and Human Services and 
Administrator, Health Resources and Services Administration (HRSA), on 
matters related to the activities of the C.W. Bill Young Cell 
Transplantation Program (Program) and the National Cord Blood Inventory 
Program.
    Agenda: The Council will discuss trends in the usage of various 
sources of blood stem cells used in unrelated blood stem cell 
transplants, utilization of cord blood, blood stem cell transplantation 
for treatment of sickle cell disease, and late effects in blood and 
marrow transplantation, among other topics. The Council will also 
receive a program update from the HRSA Division of Transplantation 
(DoT). Agenda items are subject to change as priorities indicate.
    After Council discussions, members of the public will have an 
opportunity to provide comment. Because of the Council's full agenda 
and timeframe in which to cover the agenda topics, public comment will 
be limited. All public comments will be included in the record of the 
ACBSCT meeting.
    The draft meeting agenda will be posted on www.ACBSCTmeeting.org. 
Those participating at this meeting should pre-register by visiting 
www.ACBSCTmeeting.org. The deadline to pre-register for this meeting is 
Friday, September 9, 2016. Registration will be confirmed on site. For 
all logistical questions and concerns, please contact Susie Gingrich, 
Leonard Resource Group, at (202) 289-8322 or send an email to 
[email protected].
    Participants can also join this meeting via teleconference by:

    1. (Audio Portion) Calling the Conference Phone Number (1-800-
832-0736) and providing the Participant Passcode (1337210); and
    2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro 
Meeting using the following URL https://lrg.adobeconnect.com/acbsct/ 
and entering as GUEST: (Copy and paste the link into your browser if 
it does not work directly, and enter as a guest). Participants 
should plan to call and connect 15 minutes prior to the meeting for 
logistics to be set up. If you have never attended an Adobe Connect 
meeting, please test your connection using the following URL: http://www.adobe.com/go/meeting_test. In order to obtain a quick overview, 
go to the following URL: http://www.adobe.com/go/connectpro_overview. Call (202) 289-8322 or email Susie Gingrich at 
[email protected] if you are having trouble connecting to the 
meeting site.

    Public Comment: It is preferred that persons interested in 
providing an oral presentation email a written request, along with a 
copy of your presentation, to Robert Walsh, Executive Secretary, at 
[email protected]. Requests should contain the name, address, telephone 
number, email address, and any business or professional affiliation of 
the person desiring to make an oral presentation. Groups having similar 
interests are encouraged to combine their comments and present them 
through a single representative.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request it 
during the public comment period. Public participation and ability to 
comment will be limited as time permits.

Jason E. Bennett
Director, Division of the Executive Secretariat.
[FR Doc. 2016-20198 Filed 8-23-16; 8:45 am]
BILLING CODE 4165-15-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 13, 2016, from 8:00 a.m. to 4:00 p.m. Eastern Time. September 14, 2016, from 8:00 a.m. to 12:30 p.m. Eastern Time.
ContactRobert Walsh, Executive Secretary, Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 8W60, Rockville, MD 20857; telephone (301) 443-6839.
FR Citation81 FR 57922 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR